
Sign up to save your podcasts
Or


I'm joined by Ryan Schoonmaker, Founder & CEO at Tight Line Solutions, as we explore why growth-stage medtech teams burn out fixing past shortcuts, the two-roadmap discipline almost nobody actually runs, and how to lead engineering through five-alarm fires without breaking your team.
In this episode, we dive deep into:
Why "Tight Line" Is the Right Mental Model for Product Development
→ Ryan named the company after fly fishing — keeping the right line tension is the instinct great engineering leaders have
→ Too much tension snaps the team, too little and the program gets away
→ That nascent expectation level inside a team is rarely written down but drives everything
Cutting Your Teeth at Helbling and Dexcom
→ Weekly client work at Helbling forced Ryan to communicate engineering decisions, not just make them
→ Dexcom G6 and G7 taught him that wearable medtech lives or dies on integration points between hardware, firmware, software, and human factors
→ "Killer questions" like battery size or PCB footprint can flip your entire architecture if you don't surface them early
The Two-Roadmap Playbook Most Growth-Stage Medtech Misses
→ Run an iterative roadmap on the product just launched AND a separate technology roadmap five years out
→ Biggest misstep: putting unproven technology into V1 instead of shipping fast and learning from users
→ V1 should generate revenue, expose failure modes, and feed Gen 2 — trying to make V1 perfect kills companies
The Stairstep Regulatory Strategy Sophisticated Founders Use
→ Get something cleared, then use it as your own predicate via special 510(k) or letter to file
→ While FDA reviews your initial submission, your team iterates Gen 2 in parallel
→ Ryan's seen this used to dodge a de novo pathway when one feature would have triggered it
Don't System-Architect Yourself Out of Cost Reductions
→ Most teams assume they'll automate their way to better COGS later — a $750K assembly cell and a year of capex
→ A smarter Gen 2 with fewer components and a cleaner architecture beats automation alone
→ Design Gen 1 so cost-down doesn't require a complete redesign — that's the trap that kills margin
Where Growth-Stage Companies Actually Break
→ Moving from low-cavity to high-cavity molds introduces variability that wrecks downstream bonding and welding
→ A 5% process difference when switching suppliers is enough to detonate a launch
→ Identify what's "new, unique, and difficult" upfront and characterize those subsystems deeply before scaling
Tech Debt Is Real in Hardware
→ Hardware debt costs more to fix later than to implement now — exactly like financial debt accruing interest
→ Pay it down on a "payment plan" via your Gen 2 roadmap, not by ignoring it
Best Quotes:
"You want to keep the line tight. Too much tension is going to break. Too little tension, you're going to lose the fish."
"The misstep that a lot of companies make is they try to put new technology in their products too early."
"The key is to not system-architect yourself out of cost reductions."
"Where are the gremlins hiding? Because they're always there. Let's go out and find them."
Want more insights on medtech innovation?
Subscribe to the channel so you don't miss hot takes and insider tactics from the trenches of medtech startups.
🤝 Join the #1 network for medtech innovators on the internet. Become a member to accelerate your journey, collaborate and build valuable ventures. Join for free using this link.
Find the perfect vendors for your medtech project for free at MedtechVendors - https://www.medtechvendors.com/
📈 My FREE 5-day course for Medtech Innovators to create successful ventures: https://xomedtech.com/free-course
FIND SPENCER JONES ON SOCIAL
Spencer's LinkedIn - https://www.linkedin.com/in/medtech-innovation/
XO Medtech LinkedIn - https://www.linkedin.com/company/xo-medtech/
FIND RYAN SCHOONMAKER ON SOCIAL
Ryan's LinkedIn - https://www.linkedin.com/in/ryan-schoonmaker-59048411/
Ryan's Substack - https://substack.com/@ryanschoonmaker
Tight Line Solutions Free Technical Risk Launch Scan - https://stan.store/ryanschoonmaker/p/free60-minutes
Episode Timestamps:
0:00 - Intro and the "Tight Line" mental model
5:00 - Career roots: Helbling, Dexcom, and wearable integration points
11:00 - When to start designing Gen 2 (when you submit Gen 1 to FDA)
17:00 - The COGS trap and cost-reduction architecture
22:00 - Stairstep regulatory strategy and using yourself as your own predicate
29:00 - Why Ryan started Tight Line
32:00 - Growth-stage pitfalls: scale, suppliers, and hidden cliffs
46:00 - Technical debt in hardware and how interest accrues
58:00 - Leadership in a crisis: pulling teams out and driving clarity
1:00:00 - The joy of engineering and authentic leadership
By Spencer JonesI'm joined by Ryan Schoonmaker, Founder & CEO at Tight Line Solutions, as we explore why growth-stage medtech teams burn out fixing past shortcuts, the two-roadmap discipline almost nobody actually runs, and how to lead engineering through five-alarm fires without breaking your team.
In this episode, we dive deep into:
Why "Tight Line" Is the Right Mental Model for Product Development
→ Ryan named the company after fly fishing — keeping the right line tension is the instinct great engineering leaders have
→ Too much tension snaps the team, too little and the program gets away
→ That nascent expectation level inside a team is rarely written down but drives everything
Cutting Your Teeth at Helbling and Dexcom
→ Weekly client work at Helbling forced Ryan to communicate engineering decisions, not just make them
→ Dexcom G6 and G7 taught him that wearable medtech lives or dies on integration points between hardware, firmware, software, and human factors
→ "Killer questions" like battery size or PCB footprint can flip your entire architecture if you don't surface them early
The Two-Roadmap Playbook Most Growth-Stage Medtech Misses
→ Run an iterative roadmap on the product just launched AND a separate technology roadmap five years out
→ Biggest misstep: putting unproven technology into V1 instead of shipping fast and learning from users
→ V1 should generate revenue, expose failure modes, and feed Gen 2 — trying to make V1 perfect kills companies
The Stairstep Regulatory Strategy Sophisticated Founders Use
→ Get something cleared, then use it as your own predicate via special 510(k) or letter to file
→ While FDA reviews your initial submission, your team iterates Gen 2 in parallel
→ Ryan's seen this used to dodge a de novo pathway when one feature would have triggered it
Don't System-Architect Yourself Out of Cost Reductions
→ Most teams assume they'll automate their way to better COGS later — a $750K assembly cell and a year of capex
→ A smarter Gen 2 with fewer components and a cleaner architecture beats automation alone
→ Design Gen 1 so cost-down doesn't require a complete redesign — that's the trap that kills margin
Where Growth-Stage Companies Actually Break
→ Moving from low-cavity to high-cavity molds introduces variability that wrecks downstream bonding and welding
→ A 5% process difference when switching suppliers is enough to detonate a launch
→ Identify what's "new, unique, and difficult" upfront and characterize those subsystems deeply before scaling
Tech Debt Is Real in Hardware
→ Hardware debt costs more to fix later than to implement now — exactly like financial debt accruing interest
→ Pay it down on a "payment plan" via your Gen 2 roadmap, not by ignoring it
Best Quotes:
"You want to keep the line tight. Too much tension is going to break. Too little tension, you're going to lose the fish."
"The misstep that a lot of companies make is they try to put new technology in their products too early."
"The key is to not system-architect yourself out of cost reductions."
"Where are the gremlins hiding? Because they're always there. Let's go out and find them."
Want more insights on medtech innovation?
Subscribe to the channel so you don't miss hot takes and insider tactics from the trenches of medtech startups.
🤝 Join the #1 network for medtech innovators on the internet. Become a member to accelerate your journey, collaborate and build valuable ventures. Join for free using this link.
Find the perfect vendors for your medtech project for free at MedtechVendors - https://www.medtechvendors.com/
📈 My FREE 5-day course for Medtech Innovators to create successful ventures: https://xomedtech.com/free-course
FIND SPENCER JONES ON SOCIAL
Spencer's LinkedIn - https://www.linkedin.com/in/medtech-innovation/
XO Medtech LinkedIn - https://www.linkedin.com/company/xo-medtech/
FIND RYAN SCHOONMAKER ON SOCIAL
Ryan's LinkedIn - https://www.linkedin.com/in/ryan-schoonmaker-59048411/
Ryan's Substack - https://substack.com/@ryanschoonmaker
Tight Line Solutions Free Technical Risk Launch Scan - https://stan.store/ryanschoonmaker/p/free60-minutes
Episode Timestamps:
0:00 - Intro and the "Tight Line" mental model
5:00 - Career roots: Helbling, Dexcom, and wearable integration points
11:00 - When to start designing Gen 2 (when you submit Gen 1 to FDA)
17:00 - The COGS trap and cost-reduction architecture
22:00 - Stairstep regulatory strategy and using yourself as your own predicate
29:00 - Why Ryan started Tight Line
32:00 - Growth-stage pitfalls: scale, suppliers, and hidden cliffs
46:00 - Technical debt in hardware and how interest accrues
58:00 - Leadership in a crisis: pulling teams out and driving clarity
1:00:00 - The joy of engineering and authentic leadership